See this collection of videos, news, trials, testimonials, explanations, articles, forum discussions and extensive coverage of coconut oil for Alzheimer's. Take advantage of this unique overview of authoritative research.
The ketogenic diet is a respected medical therapy with growing applications in the field of brain disorders. However, it is not a benign, holistic or natural treatment. Find out how safe it is.
Coconut oil is rich in a variety of health benefits, particularly to people with dementias such as Alzheimer's. (See articles below.) It is also rich in unhealthy saturated fats. Here are the pros and cons to help figure out if coconut oil is the right solution for your needs.
The Health Series, “The Balancing Act”, interviews a couple using Axona® in their fight against Alzheimer’s. Also see Professor Richard Isaacson, MD, sound off on this treatment.
New research shows ketogenic diets are relevant to Alzheimer's, Parkinson's, Huntington's, Vascular and Lewy Body Dementias plus other neurological disorders. This article is the first in a series on dementia, ketogenic diets and related dietary insights.
A ketogenic diet reduced amyloid beta in Alzheimer's lab mice. Amyloid beta is the infamous plaque-on-the-brain associated with Alzheimer's. (Article 4 in The Keto Dementia Diet series.)
“The discovery that anti-diabetic drugs shield synapses, offers new hope for fighting memory loss in Alzheimer’s disease,” said Professor Fernanda G. De Felice.
A Northwestern University study found that as we age, the brain may not get enough glucose (sugar, which is the brain's main source of energy). This launches a process producing amyloid plaque, which appears to be a cause of Alzheimer's.
Axona® was the first Alzheimer's-medical-food. Building on its success, MIT has developed a new and very different formulation to improve memory in dementias such as Alzheimer's. They hope to shortly introduce it as another medical food.
Ladostigil, with roots in Exelon® (rivastigmine) and the Parkinson's drug Avilect, is advancing in clinical trials. In the lab, it treated multiple symptoms of dementias such as Alzheimer's. If successful, this multifunction drug would be a significant step forward.